Symbol Name ID |
Kmt2d
lysine (K)-specific methyltransferase 2D MGI:2682319 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Kmt2ctm1.1Jwle/Kmt2c+ Kmt2dGt(RRT024)Byg/Kmt2d+ involves: 129P2/OlaHsd * 129X1/SvJ |
decreased body fat mass | J:301497 |
decreased body weight | J:301497 | |
improved glucose tolerance | J:301497 | |
increased bile salt level | J:301497 | |
increased insulin sensitivity | J:301497 | |
Kmt2dtm1.1Kaig/Kmt2d+ Ighg1tm1(cre)Cgn/Ighg1+ Tg(Vav-BCL2)69Jad/0 involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J |
increased B cell derived lymphoma incidence | J:228913 |
increased follicular lymphoma incidence | J:228913 | |
premature death | J:228913 | |
Kmt2dtm1.1Kaig/Kmt2dtm1.1Kaig Ighg1tm1(cre)Cgn/Ighg1+ Tg(Vav-BCL2)69Jad/0 involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J |
increased B cell derived lymphoma incidence | J:228913 |
increased follicular lymphoma incidence | J:228913 | |
premature death | J:228913 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|